Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $111.26 million as of January 9, 2026. Its market cap has increased by 34.05% in one year.

• Market Cap: 111.26M
• Enterprise Value: 95.44M
• 1-Year Change: 34.05%
• Ranking: #4163
• Category: Micro-Cap
• Stock Price: $3.38

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $111.26M, an increase of 33.72%. That is a compound annual growth rate of 1.08%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	111.30M	8.37%
Dec 31, 2025	102.70M	37.48%
Dec 31, 2024	74.70M	-38.06%
Dec 29, 2023	120.60M	-7.44%
Dec 30, 2022	130.30M	46.40%
Dec 31, 2021	89.00M	21.92%
Dec 31, 2020	73.00M	10.11%
Dec 31, 2019	66.30M	-10.04%
Dec 31, 2018	73.70M	106.44%
Dec 29, 2017	35.70M	-24.52%
Dec 30, 2016	47.30M	79.85%
Dec 31, 2015	26.30M	10.04%
Dec 31, 2014	23.90M	-39.34%
Dec 31, 2013	39.40M	18.32%
Dec 31, 2012	33.30M	73.44%
Dec 30, 2011	19.20M	-39.81%
Dec 31, 2010	31.90M	-65.14%
Dec 31, 2009	91.50M	61.95%
Dec 31, 2008	56.50M	-63.00%
Dec 31, 2007	152.70M	62.27%
Dec 29, 2006	94.10M	31.24%
Dec 30, 2005	71.70M	-0.42%
Dec 31, 2004	72.00M	94.07%
Dec 31, 2003	37.10M	183.21%
Dec 31, 2002	13.10M	-52.88%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	971.66B
Johnson & Johnson	495.71B
AbbVie	396.12B
UnitedHealth Group	314.19B
AstraZeneca	295.31B
Merck & Co.	275.48B
Novartis AG	273.11B
Novo Nordisk	256.73B